Stock listing
A2JQTJ Stock Price, News, Filings & Events — Crinetics Pharmaceuticals, Inc.
Selected listing: A2JQTJ · LS · EUR · DE
This page tracks Crinetics Pharmaceuticals, Inc.'s A2JQTJ:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2JQTJ:LS. A2JQTJ:LS is the stock-level entry point for investors researching Crinetics Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2JQTJ:LS
- Asset type
- Stock
- Market cap
- $9.00B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Crinetics Pharmaceuticals, Inc. A2JQTJ:LS stock context
This page tracks Crinetics Pharmaceuticals, Inc.'s A2JQTJ:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2JQTJ:LS. A2JQTJ:LS is the stock-level entry point for investors researching Crinetics Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 3, 2026
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics...
July 8, 2026
Vertex to Acquire Crinetics Pharmaceuticals
July 6, 2026
Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
June 14, 2026
Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities
June 2, 2026
Crinetics Pharmaceuticals, Inc. earnings calls
Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Crinetics Pharmaceuticals, Inc. (CRNX) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2024 Earnings Call
February 27, 2025 · Replay with transcript and chapters
Research Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for A2JQTJ:LS.
Crinetics Pharmaceuticals, Inc. company profile
View the public company page for Crinetics Pharmaceuticals, Inc. on 6ix.
Crinetics Pharmaceuticals, Inc. news
Read company news and market updates connected to Crinetics Pharmaceuticals, Inc..
Crinetics Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Crinetics Pharmaceuticals, Inc..
Alternate listings
CRNX:NASDAQ
US · USD
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is A2JQTJ:LS.
6Z4:GETTEX
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is A2JQTJ:LS.
A2JQTJ:LSX
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is A2JQTJ:LS.
CRNX:BX
CH · CHF
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is A2JQTJ:LS.
6Z4:MUN
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is A2JQTJ:LS.
CRNX:BOATS
US · USD
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is A2JQTJ:LS.
6Z4:TRADEGATE
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is A2JQTJ:LS.
6Z4:FWB
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is A2JQTJ:LS.
6Z4:DUS
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is A2JQTJ:LS.
6Z4:HAM
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is A2JQTJ:LS.
6Z4:SWB
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is A2JQTJ:LS.